drugset / Trial / NCT00002232

A Study of GENEVAX-HIV, a Possible Vaccine

NCT00002232 ↗

Phase 1 Completed Wyeth-Lederle Vaccines
Double-blindPrevention

Summary

The purpose of this study is to see if it is safe to give GENEVAX-HIV, a potential HIV vaccine, to HIV-negative volunteers. The study also compares the effects of GENEVAX-HIV injected into the muscle to the effects of the drug when injected into the skin.

Timeline

Start
—
Primary completion
—
Completion
—

Drugs

EvaluationDrugModalityDoseRoute
Subject GENEVAX-HIV Vaccine — Intramuscular